PMC:7696151 / 24666-24923 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"705","span":{"begin":18,"end":25},"obj":"Species"},{"id":"719","span":{"begin":153,"end":161},"obj":"Chemical"},{"id":"720","span":{"begin":178,"end":181},"obj":"Chemical"},{"id":"721","span":{"begin":185,"end":197},"obj":"Chemical"},{"id":"730","span":{"begin":31,"end":73},"obj":"Disease"},{"id":"731","span":{"begin":90,"end":105},"obj":"Disease"}],"attributes":[{"id":"A705","pred":"tao:has_database_id","subj":"705","obj":"Tax:9606"},{"id":"A719","pred":"tao:has_database_id","subj":"719","obj":"MESH:D013256"},{"id":"A720","pred":"tao:has_database_id","subj":"720","obj":"MESH:D006886"},{"id":"A721","pred":"tao:has_database_id","subj":"721","obj":"MESH:D013411"},{"id":"A730","pred":"tao:has_database_id","subj":"730","obj":"MESH:D001172"},{"id":"A731","pred":"tao:has_database_id","subj":"731","obj":"MESH:D006525"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Furthermore, in a patient with chronic hepatitis and rheumatoid arthritis, a low risk for hepatitis virus reactivation was observed after treatment with steroids (\u003c 7.5 mg/day), HCQ or sulfadiazine [46] in combination with antivirals as prophylaxis [47,48]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T34","span":{"begin":31,"end":48},"obj":"Phenotype"},{"id":"T35","span":{"begin":53,"end":73},"obj":"Phenotype"},{"id":"T36","span":{"begin":90,"end":99},"obj":"Phenotype"}],"attributes":[{"id":"A34","pred":"hp_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/HP_0200123"},{"id":"A35","pred":"hp_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/HP_0001370"},{"id":"A36","pred":"hp_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/HP_0012115"}],"text":"Furthermore, in a patient with chronic hepatitis and rheumatoid arthritis, a low risk for hepatitis virus reactivation was observed after treatment with steroids (\u003c 7.5 mg/day), HCQ or sulfadiazine [46] in combination with antivirals as prophylaxis [47,48]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T171","span":{"begin":0,"end":257},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Furthermore, in a patient with chronic hepatitis and rheumatoid arthritis, a low risk for hepatitis virus reactivation was observed after treatment with steroids (\u003c 7.5 mg/day), HCQ or sulfadiazine [46] in combination with antivirals as prophylaxis [47,48]."}